Allan Pamba was appointed Director Public Engagement & Access Initiatives at GlaxoSmithKline in January 2011. His role focuses on the sustainable delivery of GSK medicines and vaccines to developing countries via innovative business models.
He is also responsible for directing GSK’s external engagement activities and setting up innovative initiatives to enhance access to medicines and vaccines across 50 countries, including the UN 48 Least Developed Countries.
Allan trained as a physician in Kenya and worked in clinical care in the country for government services, mission hospitals and research hospitals. He conducted clinical trials on the management of severe malaria in children at the WellcomeTrust Research Unit in Kilifi, Kenya and established one of the country’s first HIV Comprehensive Care Clinics.
He joined GSK in 2005 and was initially involved in strategic and tactical leadership of R&D programmes in Diseases of the Developing World, in particular HIV and malaria. He led medical governance for over 30 large HIV collaborative trials in Africa and Asia and led a phase III clinical development programme with two large trials in Africa developing a new anti-malarial medication.
He has an MSc in Public Health in Developing Countries from the London School of Hygiene & Tropical Medicine.
NextBillion.net | 7 New Mobile Finance Innovations (That Have Nothing to Do With Apple) · 2 days ago
Hi Samuel, sorry we didn't get to this question before the event, but we'll see if one or both of...
NextBillion.net | google hangout bundich kayser · 2 days ago
It is interesting that the external audience has chosen to focus on the shortcomings of...
NextBillion.net | 'This isn’t what we had once hoped it would be ... so what should we do?’ · 2 days ago
I meant public spaces.
Our social enterprise, developing life skills and preventing violence in neglected neighborhoods...